The effect of orally administered marbofloxacin on the pharmacokinetics of theophylline

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 50, Issue 5, 2003, Pages 246-250

  Hirt, R A ^a   Teinfalt, M ^a   Dederichs, D ^a   Van Den Hoven, R ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CANIS FAMILIARIS;

ANTIINFECTIVE AGENT; BRONCHODILATING AGENT; MARBOFLOXACIN; QUINOLONE DERIVATIVE; THEOPHYLLINE;

ANIMAL; AREA UNDER THE CURVE; ARTICLE; DELAYED RELEASE FORMULATION; DOG; DOSE RESPONSE; DRUG INTERACTION; EVALUATION; FEMALE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; BRONCHODILATOR AGENTS; DELAYED-ACTION PREPARATIONS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; FLUOROQUINOLONES; MALE; QUINOLONES; THEOPHYLLINE;

EID: 0242317359     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.2003.00538.x     Document Type: Article

References (28)

1. Al-Turk, W. A., R. M. Shaheen, S. Othman, R. M. Khalaf, and A. S. Awidi, 1988: Effects of ofloxacin on the pharmacokinetics of a single intravenous theophylline dose. Ther. Drug Monit. 10, 160-163.
2. Anadon, A., 1999: Microsomal enzyme changes by fluoroquinolone antibiotics and macrolide antibiotics. Pharmacokinetic Drug Interactions. EAVPT on CD-ROM abstract No:G3.
3. Beckmann, J., W. Elsaber, U. Grundert-Remy, and R. Hertrampf, 1987: Enoxacin-a potent inhibitor of theophylline metabolism. Eur. J. Clin. Pharmacol. 33, 227-230.
4. Bowles, S. K., Z. Popovski, M. J. Rybak, H. B. Beckman, and D. J. Edwards, 1988: Effect of norfloxacin on theopylline pharmacokinetics at steady state. Antimicrob. Agents Chemother. 32, 510-512.
5. Cester, C. C., M. Schneider, and P. L. Toutain, 1996: Comparative kinetics of two orally administred fluoroquinolones in dog. Enrofloxacin and marbofloxacin. Revue de Médicine Véterinaire 147, 703-716.
6. Fuhr, U., G. Strobl, F. Manaut, E. M. Anders, F. Sörgel, E. Lopez de Brinas, D. T. W. Chu, A. G. Pernet, G. Mahr, F. Sanz, and A. H. Staib, 1993: Quinolone antibacterial agents: relationship between structure and in vitro inhibition of the human cytochrome P450 isoform CYP1A2. Mol. Pharmacol. 43, 191-199.
7. Ha, H. R., J. Chen, A. U. Freiburghaus, and F. Follath, 1995: Metabolism of theophylline by cDNA-expressed human cytochrome P-450. Br. J. Clin. Pharmacol. 39, 321-326.
8. Holden, R., 1988: Probably fatal interaction between ciprofloxacin and theophylline. BioMed. Central 297, 1339.
9. Intorre, L., G. Mengozzi, M. Maccheroni, S. Bertini, and G. Soldani, 1995: Enrofloxacin-theophylline interaction: influence of enrofloxacin on theophylline steady state pharmacokinetics in the beagle dog. J. Vet. Pharmacol. Ther. 18, 352-356.
10. Koritz, G. D., B. C. Mc Kiernan, C. A. Neff-Davis, and I. J. Munsiff, 1986: Bioavailability of four slow-release theophylline formulations in the Beagle dog. J. Vet. Pharmacol. Ther. 9, 293-302.
11. Kung, K., J. L. Riond, and M. Wanner, 1993: Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogs. J. Vet. Pharmacol. Ther. 16, 462-468.
12. Lagente, V., A. Hichami, E. Boichot, M. A. Martins, and P. M. Sliva, 1995: Asthma and airway inflammation: potential anti-inflammatory activities of phosphodiesterase inhibitors. Allergie et Immunologie 27, 34-39.
13. Lefebvre, H. P., M. Schneider, V. Dupouy, V. Laroute, G. Costes, L. Delesalle, and P. L. Toutian, 1998: Effect of experimental renal impairment on disposition of marbofloxacin and its metabolites in the dog. J. Vet. Pharmacol. Ther. 21, 453-461.
14. McKellar, Q. A., 1993: Pharmacokinetics and clinical effects in dogs of a sustained-release formulation of theophylline. Vet. Rec. 133, 133-136.
15. Mengozzi, G., L. Intorre, M. Maccheroni, S. Bertini, and G. Soldani, 1994: Comparative bioavailability of two sustained release theophylline formulations after multiple oral doses in the dog. Proc. 6th Eur. Assoc. Vet. Pharmacol. Ther. 24-25.
16. Mitenko, P. A., and R. I. Ogilvie, 1973: Rational intravenous doses of theophylline. N. Engl. J. Med. 289, 600-603.
17. Munsiff, I. J., B. C. McKiernan, C. A. Neff-Davis, and G. D. Koritz, 1988: Determination of the acute oral toxicity of theophylline in conscious dogs. J. Vet. Pharmacol. Ther. 11, 381-389.
18. Nielson, C. P., J. J. Crowley, M. E. Morgan, and R. E. Vestal, 1988: Polymorphonuclear leukocyteinhibition by therapeutic concentrations of theophylline is mediated by cyclic-3′, 5′-adenosine monophosphate. Am. Rev. Respir. Dis. 137, 25-30.
19. Nix, D. E., M. J. Devito, M. A. Whitbread, and J. J. Schentag, 1987: Effect of multiple dose ciprofloxacin on the pharmacokinetics of theophylline and indocyanine green. J. Antimicrob. Chemother. 19, 263-269.
20. Sarkar, M., C. Hunt, P. S. Guzelian, and T. Karnes, 1992: Characterization of human liver cytochromes P-450 involved in the theophylline metabolism. Drug. Metababol. Dispos. 20, 31-37.
21. Schwartz, J., L. Jauregui, J. Lettieri, and K. Bachmann, 1988: Impact of ciprofloxacin on theophylline concentrations and steady state concentrations in serum. Antimicrob. Agents Chemother. 32, 75-77.
22. Shibata, M., M. Wachi, M. Kagawa, J. Kojima, and K. Onodera, 2000: Acute and subacute toxicities of theophylline are directly reflected by its plasma concentration in dogs. Meth. Find. Exp. Clin. Pharmacol. 22, 173-178.
23. Sörgel, F., G. Mahr, G. R. Granneman, U. Stephan, P. Nickel, and P. Muth, 1992: Effects of 2 quinolone antibacterials, temofloxacin and enoxacin, on theophylline pharmacokinetics. Clin. Pharmacokinet 22(Suppl. 1), 65-74.
24. Suzuki, S., S. Sakumoto, H. Miyazaki, and T. Taneike, 1990: Effects of food intake on the pharmacokinetics, metabolism and urinary excretion of two sustained release theophylline preparations in nonanesthetized dogs. Nippon Yakurigaku Zasshi 95, 361-368.
25. Wanner, A., 1985: The effects of methylxanthines on airway mucociliary function. Am. J. Med. 79, 16-21.
26. Wijnands, W. J. A., C. L. A. Van Hervarden, and T. B. Vree, 1984: Enoxacin raises plasma theophylline concentrations. Lancet 2, 108-109.
27. Wijnands, W. J. A., T. B. Vree, and C. L. A. Van Hervarden, 1985: Enoxacin decreases the clearance of theophylline in man. Br. J. Clin. Pharmacol. 20, 583-588.
28. Wijnands, W. J. A., T. B. Vree, and C. L. A. Van Hervarden, 1986: The influence of quinolone derivates on theophylline clearance. Br. J. Clin. Pharmacol. 22, 677-683.